We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Price loading...
MACMILLAN Evidence-biased Antidepressant Prescription: Overmedicalisation, Flawed Research, and Conflicts of Interest
Price data last checked 107 day(s) ago - refreshing...
Price History & Forecast
No Price Data Available
Price history will appear here once data is collected from Amazon.
Price Distribution
No price data available for histogram
Description
This book addresses the over-prescribing of antidepressants in people with mostly mild and subthreshold depression. It outlines the steep increase in antidepressant prescription and critically examines the current scientific evidence on the efficacy and safety of antidepressants in depression. The book is not only concerned with the conflicting views as to whether antidepressants are useful or ineffective in various forms of depression, but also aims at detailing how flaws in the conduct and reporting of antidepressant trials have led to an overestimation of benefits and underestimation of harms. The transformation of the diagnostic concept of depression from a rare but serious disorder to an over-inclusive, highly prevalent but predominantly mild and self-limiting disorder is central to the books argument. It maintains that biological reductionism in psychiatry and pharmaceutical marketing reframed depression as a brain disorder, corroboratingthe overemphasis on drug treatment in both research and practice. Finally, the author goes on to explore how pharmaceutical companies have distorted the scientific literature on the efficacy and safety of antidepressants and how patient advocacy groups, leading academics, and medical organisations with pervasive financial ties to the industry helped to promote systematically biased benefit-harm evaluations, affecting public attitudes towards antidepressants as well as medical education, training, and practice.
Product Specifications
- Brand
- MACMILLAN
- Format
- paperback
- ASIN
- 3030825892
- Domain
- Amazon UK
- Release Date
- 11 December 2022
- Listed Since
- 13 November 2022
Barcode
No barcode data available
Similar Products You Might Like
94% match
The Myth of Depression as Disease: Limitations and Alternatives to Drug Treatment (Contemporary Psychology)
By
£50.73
07 Mar 2026
93% match
The Sedated Society: The Causes and Harms of our Psychiatric Drug Epidemic
MACMILLAN
£46.51
07 Mar 2026
93% match
Antidepressants: Types, Efficiency & Possible Side Effects (Depression-Causes, Diagnosis, and Treatment)
£66.90
02 Mar 2026
93% match
Neurobiology of Depression: Road to Novel Therapeutics
Academic Press
£101.89
11 Feb 2026
93% match
The Loss of Sadness: How psychiatry transformed normal sorrow into depressive disorder
Oxford University Press
£34.71
16 Mar 2026
93% match
The Massachusetts General Hospital Guide to Depression: New Treatment Insights and Options (Current Clinical Psychiatry)
Humana
£94.25
09 Mar 2026
93% match
CRC Press Herbal Treatment of Major Depression - Science Book
CRC Press
£95.67
04 Mar 2026
92% match
Antidepressants: Past, Present and Future: 157 (Handbook of Experimental Pharmacology, 157)
Springer
£180.00
06 Jan 2026
92% match
Pharmacotherapy of Depression
Humana
£79.93
23 Feb 2026
92% match
Antidepressants Therapy & Risk of Suicide Among Patients with Major Depressive Disorders (Psychiatry - Theory, Applications and Treatments)
£41.02
21 Feb 2026
92% match
Antidepressants: Past, Present and Future: 157 (Handbook of Experimental Pharmacology, 157)
Springer
£294.92
12 Jan 2026
92% match
Ketamine for Treatment-Resistant Depression: The First Decade of Progress
Adis
£64.63
08 Mar 2026
92% match
Drug Discovery for Psychiatric Disorders: Volume 28 (Drug Discovery Series)
Royal Society of Chemistry
£70.03
09 Mar 2026
92% match
Deprescribing in Psychiatry
Oxford University Press
£44.01
09 Feb 2026
92% match
Depressive Disorders: Mechanisms, Measurement and Management: 1180 (Advances in Experimental Medicine and Biology, 1180)
Springer
£75.01
23 Feb 2026
92% match
Major Depressive Disorder: Risk Factors, Characteristics & Treatment Options (Psychiatry - Theory, Applications and Treatments)
£252.99
13 Jan 2026
92% match
Treatments for Adolescent Depression: Theory and Practice
Oxford University Press
£38.40
23 Feb 2026
92% match
Managing Treatment-Resistant Depression: Road to Novel Therapeutics
Academic Press
£155.56
25 Jan 2026
92% match
Treatment-Resistant Mood Disorders
Cambridge University Press
£57.15
24 Feb 2026
92% match
Antidepressants (Milestones in Drug Therapy)
Birkhauser
£63.53
20 Feb 2026
92% match
Springer Understanding Depression Vol 2 - Clinical Management
Springer
£116.90
19 Apr 2026
92% match
New Rapid-acting Antidepressants (Contemporary Clinical Neuroscience)
Springer
£134.41
24 Jan 2026
92% match
Springer - Ketamine: From Abused Drug to Rapid-Acting Antidepressant
Springer
£114.72
14 Apr 2026
92% match
Psychopharmacology Reconsidered: A Concise Guide Exploring the Limits of Diagnosis and Treatment
£61.49
08 Jan 2026